Benjamin Ortiz

Benjamin Ortiz

Regeneron Pharmaceuticals Inc - Warsaw / United States
Medical and Health Sciences / Pharmacy & Pharmaceutical Sciences
AD Scientific Index ID: 4415815
-
person_outline Benjamin Ortiz's MOST POPULAR ARTICLES
1-) Omalizumab in children with uncontrolled allergic asthma: review of clinical trial and real-world experienceBE Chipps, B Lanier, H Milgrom, A Deschildre, G Hedlin, SJ Szefler, ...Journal of Allergy and Clinical Immunology 139 (5), 1431-1444, 20171492017
2-) Benefits and harms of omalizumab treatment in adolescent and adult patients with chronic idiopathic (spontaneous) urticaria: a meta-analysis of “real-world” evidenceMD Tharp, JA Bernstein, A Kavati, B Ortiz, K MacDonald, K Denhaerynck, ...JAMA dermatology 155 (1), 29-38, 20191542019
3-) Addressing the childhood asthma crisis in Harlem: the Harlem Children’s Zone Asthma InitiativeSW Nicholas, B Jean-Louis, B Ortiz, M Northridge, K Shoemaker, ...American journal of public health 95 (2), 245-249, 20051492005
4-) Effect of dupilumab on blood eosinophil counts in patients with asthma, chronic rhinosinusitis with nasal polyps, atopic dermatitis, or eosinophilic esophagitisME Wechsler, AD Klion, P Paggiaro, P Nair, D Staumont-Salle, A Radwan, ...The Journal of Allergy and Clinical Immunology: In Practice 10 (10), 2695-2709, 20221472022
5-) The national cost of asthma among school-aged children in the United StatesPW Sullivan, V Ghushchyan, P Navaratnam, HS Friedman, A Kavati, ...Annals of allergy, asthma & immunology 119 (3), 246-252. e1, 20171222017